Answers are grounded in this paper and cite their sources.
Identifies stool-derived microbial metabolites as biomarkers for colorectal cancer, indicating non-invasive screening potential.
Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide, highlighting the critical need for non-invasive, accurate, and interpretable diagnostic tools. Metabolomic profiling of fecal microbial extracellular vesicles (EVs) offers a promising yet underexplored avenue for biomarker discovery when integrated with explainable machine learning (ML) frameworks. Aim: This study aimed to identify stool-derived microbial EV metabolite biomarkers that discriminate CRC patients from healthy controls and to develop interpretable ML classifiers for non-invasive CRC detection. Methods: Metabolomic profiles of fecal microbial EVs from 76 age- and sex-comparable participants (36 CRC, 40 controls) were obtained using LC/QTOFMS and GC/TOFMS. Three ML classifiers (TPOT, LightGBM, XGBoost) were trained and evaluated through 100-repeat stratified hold-out and nested 5-fold cross-validation, with SHAP and LIME applied for global and local interpretability. Results: Fourteen metabolites were significantly dysregulated between the CRC and control groups (adjusted p < 0.05), with 13 upregulated and one (aminoisobutyric acid) downregulated. Furoic acid exhibited perfect diagnostic discrimination, followed by palmitic acid and tyramine. Nested cross-validation demonstrated robust performance: TPOT achieved AUC = 0.997 ± 0.005, sensitivity = 0.973 ± 0.022, and MCC = 0.957 ± 0.033. Hold-out validation corroborated these findings (AUC = 0.998 ± 0.008). SHAP analysis identified furoic acid, palmitic acid, and tyramine as the dominant predictive features, while aminoisobutyric acid exhibited a distinctive protective pattern. LIME analysis corroborated these findings at the individual prediction level. Conclusions: The identified fecal EV-derived metabolite panel—particularly furoic acid, palmitic acid, and tyramine—shows strong potential to predict CRC in a non-invasive, interpretable manner; however, given the modest sample size, these findings should be considered hypothesis-generating and require validation in larger, prospective, multi-center cohorts before clinical translation.
No takes yet. Share an insight, caveat, or question.
Yağın et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: